INVESTMENT AGREEMENT by and between VENAXIS, INC. And dated as ofInvestment Agreement • January 27th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • Colorado
THIS INVESTMENT AGREEMENT (this "Agreement") is entered into as of __________, 2016, by and between Venaxis, Inc., a corporation organized under the Laws of the State of Colorado ("Venaxis"), [an individual [not] residing in India/a company [not] organized under the Laws of India] ("Subscriber"). Venaxis and Subscriber are collectively referred to herein as the "parties".
MASTER AGREEMENT By and Among STRAND LIFE SCIENCES PRIVATE LIMITED and STRAND GENOMICS, INC. And VENAXIS, INC. JANUARY 26, 2016Master Agreement • January 27th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • New York
This Master Agreement, as amended, modified or supplemented from time to time (this "Agreement"), is made and entered into as of January 26, 2016, by and between Strand Life Sciences Private Limited, an Indian private limited company ("Strand"), and Strand Genomics, Inc., a Delaware corporation and wholly owned subsidiary of Strand ("Strand Genomics"), on the one hand, and Venaxis, Inc., a Colorado corporation ("Venaxis") on the other hand. Strand, Strand Genomics and Venaxis are each a "Party" to this Agreement and collectively the "Parties" to this Agreement; provided, however, that any provision of this Agreement that contemplates deliveries by, consents to, waivers of or similar provisions will mean and refer to Strand and Venaxis unless reference is made to Strand Genomics.
SHARE SALE AGREEMENTShare Sale Agreement • January 27th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • New York
THIS SHARE SALE AGREEMENT (this "Agreement") is entered into as of __________, 2016, by and between Venaxis, Inc., a corporation organized under the Laws of the State of Colorado ("Venaxis"), and [●], [an individual [not] residing in India/a company [not] organized under the Laws of India] ("Seller"). Venaxis and Seller are collectively referred to herein as the "parties" and individually as a "party".
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 27th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • New York
This Asset Purchase Agreement (this "Agreement"), dated as of January 26, 2016, is entered into by and between Strand Genomics, Inc., a corporation organized under the laws of the State of Delaware ("Seller") and Venaxis Sub Inc., a corporation organized under the laws of the State of Delaware ("Buyer").
